Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., Vanderbilt University 1973
• 

  Duke Appointment History

  • Professor of Medical Psychology in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Medical Psychology, Psychiatry & Behavioral Sciences 2006 - 2013
  • Research Professor of Medical Psychology in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Medical Psychology, Psychiatry & Behavioral Sciences 1997 - 2006
  • Associate Research Professor of Medical Psychology in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Medical Psychology, Psychiatry & Behavioral Sciences 1996 - 1997
  • Associate Professor of Medical Psychology in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Medical Psychology, Psychiatry & Behavioral Sciences 1986 - 1996
• Expertise
• 

  Global Scholarship

  • Research

    • United States of America (Country) 
• Research
• 

  Selected Grants

  • Schizophenia Liability Genes among African-Americans awarded by National Institutes of Health 2002 - 2008
  • Same awarded by National Institutes of Health 1999 - 2005
  • Same awarded by National Institutes of Health 1997 - 2003
  • Fluoxetine And Behavior Therapy In Social Phobia awarded by National Institutes of Health 1994 - 2002
  • Kava Kava in Generalized Anxiety: A Double-Blind Trial awarded by National Institute of Mental Health (NIMH) 2000 - 2002
  • Same awarded by National Institutes of Health 1997 - 2001
  • Same awarded by National Institutes of Health 1997 - 1999
  • Depression In Late Life awarded by National Institutes of Health 1995 - 1999
  • Marijuana Intoxication And Brain Activation awarded by National Institutes of Health 1996 - 1999
  • Neuroendocrine Regulation In Depression awarded by National Institutes of Health 1987 - 1999
  • Fluoxetine And Behavior Therapy In Social Phobia awarded by National Institutes of Health 1994 - 1998
  • Fluoxetine And Behavior Therapy In Social Phobia awarded by National Institutes of Health 1993 - 1998
  • Neuroendocrine Regulation In Depression awarded by National Institutes of Health 1995 - 1998
  • Marijuana Smoking And Postural Syncope awarded by National Institutes of Health 1994 - 1998
  • Cortisol Cognition Brain Atrophy And Depression awarded by National Institutes of Health 1989 - 1997
  • Fluoxetine Treatment Of Postraumatic Stress Disorder awarded by National Institutes of Health 1993 - 1997
  • Tetrahydrocannabinol And Cerebral Blood Flow awarded by National Institutes of Health 1993 - 1995
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Carroll, B. J., A. Iranmanesh, D. M. Keenan, F. Cassidy, W. H. Wilson, and J. D. Veldhuis. “Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback.” Acta Psychiatr Scand 125, no. 6 (June 2012): 478–91. https://doi.org/10.1111/j.1600-0447.2011.01821.x.
       Full Text  Link to Item
    • Carroll, B. J., F. Cassidy, D. Naftolowitz, N. E. Tatham, W. H. Wilson, A. Iranmanesh, P. Y. Liu, and J. D. Veldhuis. “Pathophysiology of hypercortisolism in depression.” Acta Psychiatr Scand Suppl, no. 433 (2007): 90–103. https://doi.org/10.1111/j.1600-0447.2007.00967.x.
       Full Text  Link to Item
    • Davidson, Jonathan R. T., Kathryn M. Connor, Michael A. Hertzberg, Richard H. Weisler, William H. Wilson, and Victoria M. Payne. “Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study.” J Clin Psychopharmacol 25, no. 2 (April 2005): 166–69. https://doi.org/10.1097/01.jcp.0000155817.21467.6c.
       Full Text  Link to Item
    • Wilson, W. H. “A visual guide to expected blood levels of long-acting injectable risperidone in clinical practice.” Journal of Psychiatric Practice 10, no. 6 (2004): 393–401. https://doi.org/10.1097/00131746-200411000-00009.
       Full Text
    • Wilson, W. H., and D. A. Bigelow. “Brain activation during affective visual cues in schizophrenia: A pilot study using fMRI [3].” Journal of Clinical Psychopharmacology 24, no. 4 (2004): 450–52.
    • Mathew, Roy J., William H. Wilson, and Robin Davis. “Postural syncope after marijuana: a transcranial Doppler study of the hemodynamics.” Pharmacol Biochem Behav 75, no. 2 (May 2003): 309–18. https://doi.org/10.1016/s0091-3057(03)00086-8.
       Full Text  Link to Item
    • Yang, Yen Kuang, Joseph P. McEvoy, William H. Wilson, Edward D. Levin, and Jed E. Rose. “Reliabilities and intercorrelations of reported and objective measures of smoking in patients with schizophrenia.” Schizophr Res 60, no. 1 (March 1, 2003): 9–12. https://doi.org/10.1016/s0920-9964(02)00208-6.
       Full Text  Link to Item
    • Mathew, Roy J., William H. Wilson, Timothy G. Turkington, Thomas C. Hawk, R Edward Coleman, Timothy R. DeGrado, and James Provenzale. “Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography.” Psychiatry Res 116, no. 3 (December 30, 2002): 173–85. https://doi.org/10.1016/s0925-4927(02)00069-0.
       Full Text  Link to Item
    • Yang, Yen Kuang, Leann Nelson, Lakshmi Kamaraju, William Wilson, and Joseph P. McEvoy. “Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia.” Neuropsychopharmacology 27, no. 4 (October 2002): 684–86. https://doi.org/10.1016/S0893-133X(02)00325-1.
       Full Text  Link to Item
    • Keefe, Richard S. E., Miriam C. Arnold, Ute J. Bayen, Joseph P. McEvoy, and William H. Wilson. “Source-monitoring deficits for self-generated stimuli in schizophrenia: multinomial modeling of data from three sources.” Schizophr Res 57, no. 1 (September 1, 2002): 51–67. https://doi.org/10.1016/s0920-9964(01)00306-1.
       Full Text  Link to Item
    • Cassidy, Frederick, Joseph P. McEvoy, Yen Kuang Yang, and William H. Wilson. “Smoking and psychosis in patients with bipolar I disorder.” Compr Psychiatry 43, no. 1 (January 2002): 63–64. https://doi.org/10.1053/comp.2002.29847.
       Full Text  Link to Item
    • Cassidy, Frederick, William H. Wilson, and Bernard J. Carroll. “Leukocytosis and hypoalbuminemia in mixed bipolar states: evidence for immune activation.” Acta Psychiatr Scand 105, no. 1 (January 2002): 60–64. https://doi.org/10.1034/j.1600-0447.2002.0_435.x.
       Full Text  Link to Item
    • Cassidy, F., J. P. McEvoy, Y. K. Yang, and W. H. Wilson. “Insight is greater in mixed than in pure manic episodes of bipolar I disorder.” J Nerv Ment Dis 189, no. 6 (June 2001): 398–99. https://doi.org/10.1097/00005053-200106000-00008.
       Full Text  Link to Item
    • Marx, C. E., E. McIntosh, W. H. Wilson, and J. P. McEvoy. “Mecamylamine increases cigarette smoking in psychiatric patients.” J Clin Psychopharmacol 20, no. 6 (December 2000): 706–7. https://doi.org/10.1097/00004714-200012000-00023.
       Full Text  Link to Item
    • Wilson, W., R. Mathew, T. Turkington, T. Hawk, R. E. Coleman, and J. Provenzale. “Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study.” J Addict Dis 19, no. 1 (2000): 1–22. https://doi.org/10.1300/J069v19n01_01.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, N. Y. Chiu, T. G. Turkington, T. R. Degrado, and R. E. Coleman. “Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration.” Acta Psychiatr Scand 100, no. 1 (July 1999): 67–75. https://doi.org/10.1111/j.1600-0447.1999.tb10916.x.
       Full Text  Link to Item
    • McEvoy, J. P., O. Freudenreich, and W. H. Wilson. “Smoking and therapeutic response to clozapine in patients with schizophrenia.” Biol Psychiatry 46, no. 1 (July 1, 1999): 125–29. https://doi.org/10.1016/s0006-3223(98)00377-1.
       Full Text  Link to Item
    • Davidson, J. R., L. A. Tupler, W. H. Wilson, and K. M. Connor. “A family study of chronic post-traumatic stress disorder following rape trauma.” J Psychiatr Res 32, no. 5 (September 1998): 301–9. https://doi.org/10.1016/S0022-3956(98)00016-8.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, T. G. Turkington, and R. E. Coleman. “Cerebellar activity and disturbed time sense after THC.” Brain Res 797, no. 2 (June 29, 1998): 183–89. https://doi.org/10.1016/s0006-8993(98)00375-8.
       Full Text  Link to Item
    • Mathew, R. J., and W. H. Wilson. “Marijuana smoking and brain morphology.” Journal of Addictive Diseases 17, no. 2 (January 1, 1998): 155.
    • Mathew, R. J., and W. H. Wilson. “Intracranial and extracranial blood flow during acute anxiety.” Psychiatry Res 74, no. 2 (May 16, 1997): 93–107. https://doi.org/10.1016/s0925-4927(97)03106-5.
       Full Text  Link to Item
    • Hege, S. G., E. H. Ellinwood, W. H. Wilson, C. A. Helligers, and S. M. Graham. “Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam.” Psychopharmacology (Berl) 131, no. 2 (May 1997): 101–7. https://doi.org/10.1007/s002130050271.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, D. Humphreys, and J. V. Lowe. “Effect of nitrous oxide on cerebral blood velocity while reclining and standing.” Biol Psychiatry 41, no. 9 (May 1, 1997): 979–84. https://doi.org/10.1016/S0006-3223(96)00159-X.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, D. Humphreys, J. V. Lowe, and K. E. Wiethe. “Cerebral vasodilation and vasoconstriction associated with acute anxiety.” Biol Psychiatry 41, no. 7 (April 1, 1997): 782–95. https://doi.org/10.1016/S0006-3223(96)00178-3.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, R. E. Coleman, T. G. Turkington, and T. R. DeGrado. “Marijuana intoxication and brain activation in marijuana smokers.” Life Sci 60, no. 23 (1997): 2075–89. https://doi.org/10.1016/s0024-3205(97)00195-1.
       Full Text  Link to Item
    • Donnelly, C. L., J. P. McEvoy, W. H. Wilson, and N. Narasimhachari. “A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia.” Biol Psychiatry 40, no. 12 (December 15, 1996): 1218–21. https://doi.org/10.1016/0006-3223(95)00650-8.
       Full Text  Link to Item
    • Levin, E. D., W. Wilson, J. E. Rose, and J. McEvoy. “Nicotine-haloperidol interactions and cognitive performance in schizophrenics.” Neuropsychopharmacology 15, no. 5 (November 1996): 429–36. https://doi.org/10.1016/S0893-133X(96)00018-8.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, J. V. Lowe, and D. Humphries. “Acute changes in cranial blood flow after cocaine hydrochloride.” Biol Psychiatry 40, no. 7 (October 1, 1996): 609–16. https://doi.org/10.1016/0006-3223(95)00033-x.
       Full Text  Link to Item
    • Mathew, R. J., J. Georgi, W. H. Wilson, and V. G. Mathew. “A retrospective study of the concept of spirituality as understood by recovering individuals.” J Subst Abuse Treat 13, no. 1 (January 1996): 67–73. https://doi.org/10.1016/0740-5472(95)02022-5.
       Full Text  Link to Item
    • McEvoy, J. P., M. Hartman, D. Gottlieb, S. Godwin, L. J. Apperson, and W. Wilson. “Common sense, insight, and neuropsychological test performance in schizophrenia patients.” Schizophr Bull 22, no. 4 (1996): 635–41. https://doi.org/10.1093/schbul/22.4.635.
       Full Text  Link to Item
    • Sundar, K. S., L. S. Kamaraju, J. McMahon, R. A. Bitonte, S. Gollapudi, W. H. Wilson, L. Y. Kong, J. S. Hong, and J. E. Lee. “Endogenous opioids and HIV infection.” Adv Exp Med Biol 402 (1996): 53–57. https://doi.org/10.1007/978-1-4613-0407-4_8.
       Full Text  Link to Item
    • VanderZwaag, C., M. McGee, J. P. McEvoy, O. Freudenreich, W. H. Wilson, and T. B. Cooper. “Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges.” American Journal of Psychiatry 153, no. 12 (1996): 1579–84.
    • Wilson, W. H. “Time required for initial improvement during clozapine treatment of refractory schizophrenia.” American Journal of Psychiatry 153, no. SUPPL. (1996): 951–52.
    • Swanson, C. L., O. Freudenreich, J. P. McEvoy, L. Nelson, L. Kamaraju, and W. H. Wilson. “Insight in schizophrenia and mania.” J Nerv Ment Dis 183, no. 12 (December 1995): 752–55. https://doi.org/10.1097/00005053-199512000-00004.
       Full Text  Link to Item
    • Sundar, K. S., L. S. Kamaraju, J. Dingfelder, J. McMahon, S. Gollapudi, W. H. Wilson, L. Y. Kong, J. S. Hong, J. M. Weiss, and J. E. Lee. “beta-Endorphin enhances the replication of neurotropic human immunodeficiency virus in fetal perivascular microglia.” J Neuroimmunol 61, no. 1 (August 1995): 97–104. https://doi.org/10.1016/0165-5728(95)00089-k.
       Full Text  Link to Item
    • Mathew, R. J., J. Georgi, W. H. Wilson, J. N. Georgi, and J. V. Lowe. “Substance abuse consultation in a teaching hospital.” N C Med J 56, no. 7 (July 1995): 329–33.
       Link to Item
    • Mathew, R. J., V. G. Mathew, W. H. Wilson, and J. M. Georgi. “Measurement of materialism and spiritualism in substance abuse research.” J Stud Alcohol 56, no. 4 (July 1995): 470–75. https://doi.org/10.15288/jsa.1995.56.470.
       Full Text  Link to Item
    • Wilson, W. H. “Do anticonvulsants hinder clozapine treatment?” Biological Psychiatry 37, no. 2 (1995): 132–33. https://doi.org/10.1016/0006-3223(94)00229-V.
       Full Text
    • Wilson, W. H., and A. M. Claussen. “18-Month outcome of clozapine treatment for 100 patients in a state psychiatric hospital.” Psychiatric Services 46, no. 4 (1995): 386–89.
    • Wolf, M., S. Wolf, and W. H. Wilson. “Clozapine treatment in Russia: A review of clinical research.” Psychiatric Services 46, no. 3 (1995): 256–59.
    • Wilson, W. H., E. H. Ellinwood, R. J. Mathew, and K. Johnson. “Effects of marijuana on performance of a computerized cognitive-neuromotor test battery.” Psychiatry Res 51, no. 2 (February 1994): 115–25. https://doi.org/10.1016/0165-1781(94)90031-0.
       Full Text  Link to Item
    • Reid, W. H., and W. H. Wilson. “Clinical usefulness of clozapine [6].” Journal of Clinical Psychiatry 55, no. 12 (1994).
    • Wilson, W. H. “Open clozapine treatment following a controlled clinical trial of lithium augmentation of haloperidol for refractory schizophrenia.” Lithium 5, no. 2 (1994): 113–14.
    • Wilson, W. H., and A. M. Claussen. “Seizures associated with clozapine treatment in a state hospital.” Journal of Clinical Psychiatry 55, no. 5 (1994): 184–88.
    • Wilson, W. H., and W. S. Appleton. “The fifth psychoactive drug usage guide [1].” Journal of Clinical Psychiatry 55, no. 1 (1994): 34–35.
    • Davidson, J. R., N. Potts, E. Richichi, R. Krishnan, S. M. Ford, R. Smith, and W. H. Wilson. “Treatment of social phobia with clonazepam and placebo.” J Clin Psychopharmacol 13, no. 6 (December 1993): 423–28.
       Link to Item
    • Wilson, W. H., and R. J. Mathew. “Asymmetry of rCBF in schizophrenia: relationship to AP-gradient and duration of illness.” Biol Psychiatry 33, no. 11–12 (June 1, 1993): 806–14. https://doi.org/10.1016/0006-3223(93)90022-6.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, D. G. Blazer, and L. K. George. “Psychiatric disorders in adult children of alcoholics: data from the Epidemiologic Catchment Area project.” Am J Psychiatry 150, no. 5 (May 1993): 793–800. https://doi.org/10.1176/ajp.150.5.793.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, D. Humphreys, J. V. Lowe, and K. E. Weithe. “Depersonalization after marijuana smoking.” Biol Psychiatry 33, no. 6 (March 15, 1993): 431–41. https://doi.org/10.1016/0006-3223(93)90171-9.
       Full Text  Link to Item
    • Cutler, D. L., W. H. Wilson, S. L. Godard, and D. A. Pollack. “Collaboration for training.” Administration and Policy in Mental Health 20, no. 6 (1993): 449–58.
    • Davidson, J. R. T., N. Potts, R. Krishnan, O. Boyko, C. Charles, R. Smith, S. Ford, L. A. Tupler, and W. Wilson. “Biology of social phobia.” European Neuropsychopharmacology 3, no. 3 (January 1, 1993): 192–93. https://doi.org/10.1016/0924-977X(93)90019-I.
       Full Text
    • Lippincott, R. C., W. H. Wilson, S. L. Godard, D. L. Cutler, and R. H. Angell. “Disseminating the partnership: The Pew Memorial Trust State-University Collaboration Project.” Administration and Policy in Mental Health 20, no. 6 (1993): 471–79. https://doi.org/10.1007/BF00706291.
       Full Text
    • Mathew, R. J., and W. H. Wilson. “Acute changes in cerebral blood flow after smoking marijuana.” Life Sci 52, no. 8 (1993): 757–67. https://doi.org/10.1016/0024-3205(93)90239-y.
       Full Text  Link to Item
    • Schalk, D. C., and W. H. Wilson. “Impact of clozapine on medication use in a state hospital.” Hospital Pharmacy 28, no. 7 (1993): 647–53.
    • Wilson, W. H. “Response to Fred W. Becker's 'The politics of closing state mental hospitals'.” Community Mental Health Journal 29, no. 2 (1993): 115–17.
    • Wilson, W. H. “Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: A double blind, placebo controlled, parallel design clinical trial.” Psychopharmacology 111, no. 3 (1993): 359–66. https://doi.org/10.1007/BF02244953.
       Full Text
    • Wilson, W. H., S. L. Godard, and D. L. Cutler. “State hospital curriculum: Public academic liaison for psychiatric education.” Administration and Policy in Mental Health 20, no. 6 (1993): 459–69.
    • Mathew, R. J., W. H. Wilson, D. F. Humphreys, J. V. Lowe, and K. E. Wiethe. “Regional cerebral blood flow after marijuana smoking.” J Cereb Blood Flow Metab 12, no. 5 (September 1992): 750–58. https://doi.org/10.1038/jcbfm.1992.106.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, D. Humphreys, J. V. Lowe, and K. E. Wiethe. “Middle cerebral artery velocity during upright posture after marijuana smoking.” Acta Psychiatr Scand 86, no. 2 (August 1992): 173–78. https://doi.org/10.1111/j.1600-0447.1992.tb03247.x.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, D. F. Humphreys, J. V. Lowe, and K. E. Wiethe. “Changes in middle cerebral artery velocity after marijuana.” Biol Psychiatry 32, no. 2 (July 15, 1992): 164–69. https://doi.org/10.1016/0006-3223(92)90019-v.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, D. F. Humphreys, J. V. Lowe, and K. E. Wiethe. “Changes in cerebral blood velocity after intravenous diazepam.” Biol Psychiatry 31, no. 7 (April 1, 1992): 690–97. https://doi.org/10.1016/0006-3223(92)90278-8.
       Full Text  Link to Item
    • Krishnan, K. R., D. Reed, W. H. Wilson, W. B. Saunders, J. C. Ritchie, C. B. Nemeroff, and B. J. Carroll. “RU486 in depression.” Prog Neuropsychopharmacol Biol Psychiatry 16, no. 6 (1992): 913–20. https://doi.org/10.1016/0278-5846(92)90109-r.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, and F. T. Melges. “Temporal disintegration and its psychological and physiological correlates: Changes in the experience of time after marijuana smoking.” Annals of Clinical Psychiatry 4, no. 4 (January 1, 1992): 235–45. https://doi.org/10.3109/10401239209150455.
       Full Text
    • Wilson, W. H. “Response to Kahn and Kahn, "group treatment assignment for outpatients with schizophrenia".” Community Mental Health Journal 28, no. 6 (1992): 551–53. https://doi.org/10.1007/BF00754200.
       Full Text
    • Wilson, W. H. “Clinical review of clozapine treatment in a state hospital.” Hospital and Community Psychiatry 43, no. 7 (1992): 700–703.
    • Wilson, W. H. “Psychiatric education in the State Hospital: A current approach.” Community Mental Health Journal 28, no. 1 (1992): 51–59.
    • Wilson, W. H., and D. A. Stout. “The spectrum of clozapine response in refractory schizophrenia: Four case reports.” Annals of Clinical Psychiatry 4, no. 3 (1992): 201–6.
    • Davidson, J. R., N. L. Potts, E. A. Richichi, S. M. Ford, K. R. Krishnan, R. D. Smith, and W. Wilson. “The Brief Social Phobia Scale.” J Clin Psychiatry 52 Suppl (November 1991): 48–51. https://doi.org/10.1037/t07672-000.
       Full Text  Link to Item
    • Mathew, R. J., and W. H. Wilson. “Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow.” Psychiatry Res 40, no. 2 (October 1991): 125–34. https://doi.org/10.1016/0925-4927(91)90004-a.
       Full Text  Link to Item
    • Mathew, R. J., and W. H. Wilson. “Substance abuse and cerebral blood flow.” Am J Psychiatry 148, no. 3 (March 1991): 292–305. https://doi.org/10.1176/ajp.148.3.292.
       Full Text  Link to Item
    • Erwin, C. W., A. C. Erwin, J. W. Hartwell, and W. H. Wilson. “P100 latency as a function of head size.” American Journal of Eeg Technology 31, no. 4 (January 1, 1991): 279–88. https://doi.org/10.1080/00029238.1991.11080380.
       Full Text
    • Krishnan, K. R., J. C. Ritchie, A. N. Manepalli, W. H. Wilson, W. B. Saunders, S. S. Venkataraman, and B. J. Carroll. “Role of serotonin in hypothalamo pituitary adrenal axis escape from dexamethasone suppression.” Prog Neuropsychopharmacol Biol Psychiatry 15, no. 5 (1991): 637–42. https://doi.org/10.1016/0278-5846(91)90053-4.
       Full Text  Link to Item
    • Mathew, R. J., and W. H. Wilson. “Changes in cerebral blood flow after diazepam evaluated with 3 measurement techniques.” European Neuropsychopharmacology 1, no. 3 (January 1, 1991): 471. https://doi.org/10.1016/0924-977x(91)90696-r.
       Full Text
    • McEvoy, J. P., N. R. Schooler, and W. H. Wilson. “Predictors of therapeutic response to haloperidol in acute schizophrenia.” Psychopharmacol Bull 27, no. 2 (1991): 97–101.
       Link to Item
    • Krishnan, K. R., J. C. Ritchie, W. Saunders, W. Wilson, C. B. Nemeroff, and B. J. Carroll. “Nocturnal and early morning secretion of ACTH and cortisol in humans.” Biol Psychiatry 28, no. 1 (July 1, 1990): 47–57. https://doi.org/10.1016/0006-3223(90)90431-z.
       Full Text  Link to Item
    • Mathew, R. J., and W. H. Wilson. “Anxiety and cerebral blood flow.” Am J Psychiatry 147, no. 7 (July 1990): 838–49. https://doi.org/10.1176/ajp.147.7.838.
       Full Text  Link to Item
    • Mathew, R. J., and W. H. Wilson. “Behavioral and cerebrovascular effects of caffeine in patients with anxiety disorders.” Acta Psychiatr Scand 82, no. 1 (July 1990): 17–22. https://doi.org/10.1111/j.1600-0447.1990.tb01348.x.
       Full Text  Link to Item
    • Mathew, R. J., and W. H. Wilson. “Cerebral blood flow responses to inhaled carbon dioxide in schizophrenia.” Acta Psychiatr Scand 81, no. 6 (June 1990): 497–506. https://doi.org/10.1111/j.1600-0447.1990.tb05488.x.
       Full Text  Link to Item
    • Mathew, R. J., and W. H. Wilson. “Chronicity and a low anteroposterior gradient of cerebral blood flow in schizophrenia.” Am J Psychiatry 147, no. 2 (February 1990): 211–13. https://doi.org/10.1176/ajp.147.2.211.
       Full Text  Link to Item
    • Wilson, W. H., R. J. Diamond, and R. M. Factor. “Clinical Care Update: The chronically mentally ill group treatment for individuals with schizophrenia.” Community Mental Health Journal 26, no. 4 (1990): 361–72. https://doi.org/10.1007/BF00752726.
       Full Text
    • Mathew, R. J., W. H. Wilson, and S. Tant. “Responses to hypercarbia induced by acetazolamide in panic disorder patients.” Am J Psychiatry 146, no. 8 (August 1989): 996–1000. https://doi.org/10.1176/ajp.146.8.996.
       Full Text  Link to Item
    • Mathew, R. J., and W. H. Wilson. “Cerebral blood flow responses to CO2 and acetazolamide: the effect of anxiety.” Psychiatry Res 28, no. 2 (May 1989): 241–42. https://doi.org/10.1016/0165-1781(89)90050-4.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, and S. R. Tant. “Regional cerebral blood flow changes associated with amyl nitrite inhalation.” Br J Addict 84, no. 3 (March 1989): 293–99. https://doi.org/10.1111/j.1360-0443.1989.tb03462.x.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, and S. R. Tant. “Acute changes in cerebral blood flow associated with marijuana smoking.” Acta Psychiatr Scand 79, no. 2 (February 1989): 118–28. https://doi.org/10.1111/j.1600-0447.1989.tb08579.x.
       Full Text  Link to Item
    • Coffey, C. E., M. P. Bryden, E. S. Schroering, W. H. Wilson, and R. J. Mathew. “Regional cerebral blood flow correlates of a dichotic listening task.” J Neuropsychiatry Clin Neurosci 1, no. 1 (1989): 46–52. https://doi.org/10.1176/jnp.1.1.46.
       Full Text  Link to Item
    • Daniel, D. G., R. J. Mathew, and W. H. Wilson. “Sex roles and regional cerebral blood flow.” Psychiatry Res 27, no. 1 (January 1989): 55–64. https://doi.org/10.1016/0165-1781(89)90009-7.
       Full Text  Link to Item
    • Mathew, R. J., and W. H. Wilson. “Changes in cerebral blood flow and mental state after amphetamine challenge in schizophrenic patients.” Neuropsychobiology 21, no. 3 (1989): 117–23. https://doi.org/10.1159/000118564.
       Full Text  Link to Item
    • Wilson, W. H. “Diagnostic consultation to a state hospital.” Hospital and Community Psychiatry 40, no. 12 (1989): 1290–93.
    • Naylor, M. R., K. R. Krishnan, A. N. Manepalli, J. C. Ritchie, W. H. Wilson, and B. J. Carroll. “Circadian rhythm of adrenergic regulation of adrenocorticotropin and cortisol secretion in man.” J Clin Endocrinol Metab 67, no. 2 (August 1988): 404–6. https://doi.org/10.1210/jcem-67-2-404.
       Full Text  Link to Item
    • Mathew, R. J., W. H. Wilson, S. R. Tant, L. Robinson, and R. Prakash. “Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia.” Arch Gen Psychiatry 45, no. 6 (June 1988): 542–49. https://doi.org/10.1001/archpsyc.1988.01800300038004.
       Full Text  Link to Item
    • Mathew, R. J., and W. H. Wilson. “Cerebral blood flow changes induced by CO2 in anxiety.” Psychiatry Res 23, no. 3 (March 1988): 285–94. https://doi.org/10.1016/0165-1781(88)90019-4.
       Full Text  Link to Item
    • Oehler, J. M., C. O. Eckerman, and W. H. Wilson. “Social stimulation and the regulation of premature infants' state prior to term age.” Infant Behavior and Development 11, no. 3 (January 1, 1988): 333–51. https://doi.org/10.1016/0163-6383(88)90018-5.
       Full Text
    • Wilson, W. H., J. Rasmussen, B. Vause, and G. Manov. “Double‐blind placebo‐controlled study of the autonomic effects of clovoxamine, imipramine, and amitriptyline in normal volunteers.” Drug Development Research 14, no. 1 (January 1, 1988): 75–84. https://doi.org/10.1002/ddr.430140107.
       Full Text
    • Mathew, R. J., and W. H. Wilson. “Elevated hematocrit in patients with schizophrenia.” Biol Psychiatry 22, no. 7 (July 1987): 907–10. https://doi.org/10.1016/0006-3223(87)90089-8.
       Full Text  Link to Item
    • Coffey, C. E., R. D. Weiner, P. E. Hinkle, M. Cress, G. Daughtry, and W. H. Wilson. “Augmentation of ECT seizures with caffeine.” Biol Psychiatry 22, no. 5 (May 1987): 637–49. https://doi.org/10.1016/0006-3223(87)90191-0.
       Full Text  Link to Item
    • Guy, W., W. H. Wilson, B. Brooking, and O. K. Fjetland. “Intra-interrater reliability of SAFTEE using videotape interviews and clinical trial data.” Psychopharmacology Bulletin 23, no. 1 (1987): 93–96.
    • Mathew, R. J., W. H. Wilson, and P. M. Nicassio. “Cerebral ischemic symptoms in anxiety disorders.” American Journal of Psychiatry 144, no. 2 (1987): 265-.
    • Wilson, W. H. “PIP syndrome.” Journal of Clinical Psychiatry 48, no. 4 (1987): 173-.
    • Ban, T. A., W. Guy, and W. H. Wilson. “Research methodology and the pharmacotherapy of the chronic schizophrenias.” Psychopharmacology Bulletin 22, no. 1 (1986): 36–41.
    • Guy, W., G. Manov, and W. H. Wilson. “Double-blind dose determination study of a new antidepressant-sertraline.” Drug Development Research 9, no. 4 (1986): 267–72.
    • Guy, W., T. A. Ban, and W. H. Wilson. “The prevalence of abnormal involuntary movements among chronic schizophrenics.” International Clinical Psychopharmacology 1, no. 2 (1986): 134–44.
    • Guy, W., W. H. Wilson, B. Brooking, G. Manov, and O. Fjetland. “Reliability and validity of SAFTEE: Preliminary analyses.” Psychopharmacology Bulletin 22, no. 2 (1986): 397–401.
    • Mathew, R. J., W. H. Wilson, and S. R. Tant. “Determinants of resting regional cerebral blood flow in normal subjects.” Biological Psychiatry 21, no. 10 (1986): 907–14.
    • Mathew, R. J., W. H. Wilson, and S. Tant. “Caffeine-induced cerebral blood flow changes in schizophrenia.” European Archives of Psychiatry and Neurological Sciences 235, no. 4 (1986): 206–9.
    • Mathew, R. J., and W. H. Wilson. “Regional cerebral blood flow changes associated with ethanol intoxication.” Stroke 17, no. 6 (1986): 1156–59.
    • Mathew, R. J., and W. H. Wilson. “Hematocrit and anxiety.” Journal of Psychosomatic Research 30, no. 3 (1986): 307–11.
    • Wilson, W. H. “Lithium in schizophrenia.” Hospital and Community Psychiatry 37, no. 12 (1986): 1267-.
    • Wilson, W. H., T. A. Ban, and W. Guy. “Flexible system criteria in chronic schizophrenia.” Comprehensive Psychiatry 27, no. 3 (1986): 259–65.
    • Wilson, W. H., T. Ban, and B. Coleman. “The effects of clovoxamine on sleep of normal volunteers: A double-blind placebo-controlled study.” Drug Development Research 9, no. 4 (1986): 293–98.
    • Ban, T. A., W. Guy, and W. H. Wilson. “Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients.” Canadian Journal of Psychiatry 30, no. 6 (1985): 406–8.
    • Ban, T. A., W. Guy, and W. H. Wilson. “The AMDP-system in chronic hospitalized schizophrenics.” Comprehensive Psychiatry 26, no. 4 (1985): 370–74.
    • Guy, W., T. A. Ban, and W. H. Wilson. “An international survey of tardive dyskinesia.” Progress in Neuro Psychopharmacology and Biological Psychiatry 9, no. 4 (1985): 401–5.
    • Mathew, R. J., P. Rabin, W. J. Stone, and W. H. Wilson. “Regional cerebral blood flow in dialysis encephalopathy and primary degenerative dementia.” Kidney International 28, no. 1 (1985): 64–68.
    • Mathew, R. J., W. H. Wilson, and D. G. Daniel. “The effect of nonsedating doses of diazepam on regional cerebral blood flow.” Biological Psychiatry 20, no. 10 (1985): 1109–16.
    • Mathew, R. J., and W. H. Wilson. “Dextroamphetamine-induced changes in regional cerebral blood flow.” Psychopharmacology 87, no. 3 (1985): 298–302.
    • Mathew, R. J., and W. H. Wilson. “Caffeine induced changes in cerebral circulation.” Stroke 16, no. 5 (1985): 814–17.
    • Mathew, R. J., and W. H. Wilson. “Caffeine consumption, withdrawal and cerebral blood flow.” Headache 25, no. 6 (1985): 305–9.
    • Wilson, W. H., R. J. Diamond, and R. M. Factor. “A psychotherapeutic approach to task-oriented groups of severely ill patients.” Yale Journal of Biology and Medicine 58, no. 4 (1985): 363–72.
    • Wilson, W. H., T. A. Ban, and W. Guy. “Pharmacotherapy of chronic hospitalized schizophrenics: Prescription practices.” Neuropsychobiology 14, no. 2 (1985): 75–82.
    • Ban, T. A., W. Guy, and W. H. Wilson. “Description and distribution of the subtypes of chronic schizophrenia based on Leonhard's classification.” Psychiatric Developments 2, no. 3 (1984): 179–99.
    • Ban, T. A., W. Guy, and W. H. Wilson. “The psychopharmacological treatment of depression in the medically ill patient.” Canadian Journal of Psychiatry 29, no. 6 (1984): 461–66.
    • Ban, T. A., W. Guy, and W. H. Wilson. “Pharmacotherapy of chronic hospitalized schizophrenics: Diagnosis and treatment.” Psychiatric Journal of the University of Ottawa 9, no. 4 (1984): 191–95.
    • Ban, T. A., W. Guy, and W. H. Wilson. “Leonhard's classification of the chronic schizophrenias.” Canadian Journal of Psychiatry 29, no. 6 (1984): 467–72.
    • Ban, T. A., W. Guy, and W. H. Wilson. “Approaches to the management of the acutely psychotic patient.” Psychiatric Journal of the University of Ottawa 9, no. 1 (1984): 36–41.
    • Guy, W., W. H. Wilson, T. A. Ban, D. L. King, G. Manov, and O. K. Fjetland. “A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.” Psychopharmacology Bulletin 20, no. 1 (1984): 73–78.
    • Guy, W., W. H. Wilson, and T. A. Ban. “A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.” Drug Development Research 4, no. 2 (1984): 143–53.
    • Kelwala, S., T. A. Ban, S. A. Berney, and W. H. Wilson. “Rapid tranquilization: A comparative study of thiothixene and haloperidol.” Progress in Neuro Psychopharmacology and Biological Psychiatry 8, no. 1 (1984): 77–83.
    • Wilson, W. H. “Catatonia and encephalopathy following a disulfiram overdose.” Wisconsin Medical Journal 83, no. 9 (1984): 15–16.
    • Wilson, W. H. “Disulfiram and encephalopathy.” Hospital and Community Psychiatry 35, no. 5 (1984): 496–97.
    • Wilson, W. H., and S. J. Weiler. “Case report of phenothiazine-induced torsade de pointes.” American Journal of Psychiatry 141, no. 10 (1984): 1265–66.
    • Ban, T. A., S. Kelwala, and W. H. Wilson. “Specific responses to drug therapy and Leonhard classification of chronic schizophrenia.” Psychiatria Et Neurologia Japonica  Seishin Shinkeigaku Zasshi 85, no. 9 (1983): 598–600.
    • Ban, T. A., W. Guy, and W. H. Wilson. “Organizing and conducting clinical trials.” Neuropsychobiology 10, no. 2–3 (1983): 137–40.
    • Guy, W., G. Manov, W. H. Wilson, T. A. Ban, O. K. Fjetland, P. J. Manberg, and A. T. Dren. “Psychotropic actions of BW 234U in the treatment of inpatient schizophrenics: A dose‐range study.” Drug Development Research 3, no. 3 (January 1, 1983): 245–52. https://doi.org/10.1002/ddr.430030306.
       Full Text
    • Lehmann, H. E., W. H. Wilson, and M. Deutsch. “Minimal maintenance medication: Effects of three dose schedules on relapse rates and symptoms in chronic schizophrenic outpatients.” Comprehensive Psychiatry 24, no. 4 (1983): 293–303.
    • Mathew, R. J., and W. H. Wilson. “Carbon dioxide levels and cerebral blood flow.” Archives of General Psychiatry 40, no. 12 (1983): 1343–44.
    • Wilson, W. H., H. Higano, Y. Papadatos, S. Kelwala, and T. A. Ban. “A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers.” British Journal of Clinical Pharmacology 15, no. Suppl. 3 (1983): 385S-392S.
    • Wilson, W. H., H. Higano, and J. Papadatos. “Autonomic effects of fluvoxamine versus amitriptyline, doxepin, and placebo.” Psychopharmacology Bulletin 19, no. 1 (1983): 111–12.
    • Wilson, W. H., and T. A. Ban. “Distribution of Leonhard's subtypes of chronic schizophrenia in two cultures.” Canadian Journal of Psychiatry 28, no. 3 (1983): 197–98.
    • Ban, T. A., M. Fujimori, W. M. Petrie, M. Ragheb, and W. H. Wilson. “Systematic studies with amoxapine, a new antidepressant.” International Pharmacopsychiatry 17, no. 1 (1982): 18–27.
    • Ban, T. A., W. Guy, W. H. Wilson, and S. Kelwala. “Psychopharmacology and Leonhard's classification of chronic schizophrenias.” International Pharmacopsychiatry 17, no. 3 (1982): 153–62.
    • Guy, W., T. A. Ban, J. P. McEvoy, W. M. Petrie, W. H. Wilson, and J. D. Schaffer. “A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.” International Pharmacopsychiatry 17, no. 1 (1982): 36–42.
    • McEvoy, J. P., W. H. Wilson, T. A. Ban, J. O. Brannen, and S. Berney. “Bromperidol maintenance in schizophrenia.” Pharmacopsychiatria 15, no. 3 (1982): 95–96.
    • Mcevoy, J. P., J. Libiger, W. H. Wilson, T. A. Ban, S. Berney, and W. Guy. “Viloxazine HCl in the treatment of endogenous depression: A standard (imipramine) controlled clinical study.” Journal of Clinical Psychiatry 43, no. 3 (1982): 111–12.
    • Petrie, W. M., T. A. Ban, S. Berney, M. Fujimori, W. Guy, M. Ragheb, W. H. Wilson, and J. D. Schaffer. “Loxapine in psychogeriatrics: A placebo- and standard-controlled clinical investigation.” Journal of Clinical Psychopharmacology 2, no. 2 (1982): 122–26.
    • Petrie, W. M., T. A. Ban, W. H. Wilson, R. C. Jamieson, and W. Guy. “Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study.” International Pharmacopsychiatry 17, no. 4 (1982): 280–86.
    • Petrie, W. M., W. H. Wilson, R. C. Jamieson, and T. A. Ban. “Viloxazine and amitriptyline in endogenous depression.” Drug Development Research 2, no. 2 (1982): 215–18.
    • Wilson, W. H., W. Guy, and T. A. Ban. “A double-blind dose-determination study with flutroline: A new neuroleptic.” Drug Development Research 2, no. 4 (1982): 357–62.
    • Wilson, W. H., and T. A. Ban. “Repeated-measures Latin square designs in clinical pharmacology.” Methods and Findings in Experimental and Clinical Pharmacology 4, no. 1 (1982): 37–42.
    • Ban, T. A., and W. H. Wilson. “Multicenter clinical trials: methodological aspects.” Modern Problems of Pharmacopsychiatry 16 (1981): 9–20.
    • Brannen, J. O., J. P. McEvoy, W. H. Wilson, W. M. Petrie, T. A. Ban, S. A. Berney, and J. D. Schaffer. “A double-blind comparison of bromperidol and haloperidol in newly admitted schizophrenic patients.” Pharmacopsychiatria 14, no. 4 (1981): 139–40.
    • McEvoy, J. P., J. A. Jr, W. H. Wilson, W. Guy, and L. Hawkins. “Measuring chronic schizophrenic patients' attitudes toward their illness and treatment.” Hospital and Community Psychiatry 32, no. 12 (1981): 856–58.
    • Ragheb, M., W. H. Wilson, T. A. Ban, and J. O. Brannen. “Amoxapine: Once versus divided daily doses in neurotic and endogenous depression.” Journal of Clinical Psychiatry 42, no. 8 (1981): 318–21.
    • Wilson, W. H., W. M. Petrie, T. A. Ban, and D. E. barry. “The effects of amoxapine and ethanol on psychomotor skills related to driving: A placebo and standard controlled study.” Progress in Neuro Psychopharmacology 5, no. 3 (1981): 263–70.
    • Wilson, W. H., W. M. Petrie, and T. A. Ban. “Effects of viloxazine with and without alcohol on performance tests related to driving in normal volunteers.” Drug Development Research 1, no. 3 (1981): 223–28.
    • Ban, T. A., J. P. McEvoy, and W. H. Wilson. “Viloxazine: A review of the literature.” International Pharmacopsychiatry 15, no. 2 (1980): 118–23.
    • Ban, T. A., W. H. Wilson, and J. P. McEvoy. “Amoxapine: A review of literature.” International Pharmacopsychiatry 15, no. 3 (1980): 166–70.
    • Guy, W., M. Ragheb, and W. H. Wilson. “Utility of videotape in establishing interrater reliability.” Psychopharmacology Bulletin 16, no. 3 (1980): 71–74.
    • McEvoy, J. P., S. Berney, W. H. Wilson, T. A. Ban, and W. Guy. “A double-blind comparison of three dosages of flutroline (CP-36,584) in the treatment of schizophrenia.” International Pharmacopsychiatry 15, no. 5 (1980): 318–24.
    • Petrie, W. M., J. P. McEvoy, W. H. Wilson, T. A. Ban, and W. Guy. “Viloxazine in the treatment of depressive neurosis: A placebo and standard (imipramine) controlled clinical study.” International Pharmacopsychiatry 15, no. 3 (1980): 193–96.
    • Petrie, W. M., W. H. Wilson, T. A. Ban, W. Guy, and J. D. Schaffer. “Mianserin: Determination of therapeutic dose range.” International Pharmacopsychiatry 15, no. 2 (1980): 111–17.
    • Wilson, W. H., F. R. Freemon, T. A. Ban, W. M. Petrie, and C. L. Clinton. “Acute effects of viloxazine HCl and flurazepam when given alone and in combination on sleep EEG: A double-blind interaction study with normals.” The Pavlovian Journal of Biological Science : Official Journal of the Pavlovian 15, no. 2 (1980): 68–73. https://doi.org/10.1007/BF03003685.
       Full Text
    • Wilson, W. H., W. M. Petrie, and T. A. Ban. “Possible lack of anticholinergic effects with mianserin: A pilot study.” Journal of Clinical Psychiatry 41, no. 2 (1980): 63–65.
• Scholarly, Clinical, & Service Activities
• 

  Presentations & Appearances

  • “Ecosystem Services of Urban Trees: Air, heat, water, and people” 2009 NC Urban Forestry Conference. Winston-Salem, NC.. December 16, 2009  2009
  • “Phenology of an Urban Heat Island: The Ghost of Trees Past”, Invited \textit{Tree Physiology} Talk. 5th International Canopy Conference 2009. Bangalore, India.. December 16, 2009  2009

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.